Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tear Lipid Layer Thickness With Emollient Eye Drops
NCT03380624Phase 4Completed
- Sponsor
- The Ohio State University
- Start
- Mar 2017
- Primary completion
- Jun 2018
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of Optive Advanced in dry eye syndrome (DED), sponsored by The Ohio State University. Started Mar 2017; status: completed.
02
Drugs
Optive Advanced
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03380624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380624.